Health & Biotech
Encouraging signs for MGC Pharma after cannabinoid treatment for aggressive brain cancer breakthrough
Health & Biotech
ASX Health Stocks: Kazia Therapeutics gets crucial designation status from the US FDA
Health & Biotech
Weed Week: Cannabis-feed for chickens and cannabis campaigner nabs Queen’s Birthday honour
Health & Biotech
ASX Health Stocks: Proteomics proves it can manufacture at scale, GTG sees pathway to the US
Health & Biotech
Pitt Street Research thinks Skin Elements’ stock price is well undervalued
Health & Biotech
Nutritional Growth Solutions set to grab a golden link in major US supermarket chain
Health & Biotech
ASX Health Stocks: Neuroscientific says EmtinB shows positive signs, expects full results in H2
Health & Biotech
A big RAP: This micro cap biotech jumped 50% on Tuesday while the rest of the market bled out
Health & Biotech
We’re gonna hear them roar, Osteopore deal to enter South Africa sees it with presence on every continent
Health & Biotech
PharmAust and FightMND band together to fight against Motor Neurone Disease
Health & Biotech
ASX Health Stocks: Telix seeks FDA approval for Illucix; Chimeric releases viral vector
Health & Biotech
ASX Health Stocks: Neurotech says its cannabis strain works well when combined with Diclofenac
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.